These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 16908131)
1. The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells. Albanese P; Belin MF; Delattre O Eur J Cancer; 2006 Sep; 42(14):2326-34. PubMed ID: 16908131 [TBL] [Abstract][Full Text] [Related]
2. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors. Caramel J; Medjkane S; Quignon F; Delattre O Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027 [TBL] [Abstract][Full Text] [Related]
3. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival. Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802 [TBL] [Abstract][Full Text] [Related]
4. RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1. Caramel J; Quignon F; Delattre O Cancer Res; 2008 Aug; 68(15):6154-61. PubMed ID: 18676838 [TBL] [Abstract][Full Text] [Related]
5. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle. Versteege I; Medjkane S; Rouillard D; Delattre O Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744 [TBL] [Abstract][Full Text] [Related]
6. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters. Kuwahara Y; Wei D; Durand J; Weissman BE Mol Cancer Res; 2013 Mar; 11(3):251-60. PubMed ID: 23364536 [TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization. Medjkane S; Novikov E; Versteege I; Delattre O Cancer Res; 2004 May; 64(10):3406-13. PubMed ID: 15150092 [TBL] [Abstract][Full Text] [Related]
8. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors. Uno K; Takita J; Yokomori K; Tanaka Y; Ohta S; Shimada H; Gilles FH; Sugita K; Abe S; Sako M; Hashizume K; Hayashi Y Genes Chromosomes Cancer; 2002 May; 34(1):33-41. PubMed ID: 11921280 [TBL] [Abstract][Full Text] [Related]
9. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Versteege I; Sévenet N; Lange J; Rousseau-Merck MF; Ambros P; Handgretinger R; Aurias A; Delattre O Nature; 1998 Jul; 394(6689):203-6. PubMed ID: 9671307 [TBL] [Abstract][Full Text] [Related]
11. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049 [TBL] [Abstract][Full Text] [Related]
12. Knock down of hSNF5/Ini1 causes cell cycle arrest and apoptosis in a p53-dependent manner. Kato H; Honma R; Sanda T; Fujiwara T; Ito E; Yanagisawa Y; Imai J; Okamoto T; Watanabe S Biochem Biophys Res Commun; 2007 Sep; 361(3):580-5. PubMed ID: 17669367 [TBL] [Abstract][Full Text] [Related]
13. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Zhang ZK; Davies KP; Allen J; Zhu L; Pestell RG; Zagzag D; Kalpana GV Mol Cell Biol; 2002 Aug; 22(16):5975-88. PubMed ID: 12138206 [TBL] [Abstract][Full Text] [Related]
14. INI1 induces interferon signaling and spindle checkpoint in rhabdoid tumors. Morozov A; Lee SJ; Zhang ZK; Cimica V; Zagzag D; Kalpana GV Clin Cancer Res; 2007 Aug; 13(16):4721-30. PubMed ID: 17699849 [TBL] [Abstract][Full Text] [Related]
15. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Sévenet N; Lellouch-Tubiana A; Schofield D; Hoang-Xuan K; Gessler M; Birnbaum D; Jeanpierre C; Jouvet A; Delattre O Hum Mol Genet; 1999 Dec; 8(13):2359-68. PubMed ID: 10556283 [TBL] [Abstract][Full Text] [Related]
16. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes. Doan DN; Veal TM; Yan Z; Wang W; Jones SN; Imbalzano AN Oncogene; 2004 Apr; 23(19):3462-73. PubMed ID: 14990991 [TBL] [Abstract][Full Text] [Related]
17. The mammalian SWI/SNF complex and the control of cell growth. Muchardt C; Yaniv M Semin Cell Dev Biol; 1999 Apr; 10(2):189-95. PubMed ID: 10441072 [TBL] [Abstract][Full Text] [Related]
18. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16. Kuroda H; Moritake H; Sawada K; Kuwahara Y; Imoto I; Inazawa J; Sugimoto T Cancer Genet Cytogenet; 2005 Apr; 158(2):172-9. PubMed ID: 15796965 [TBL] [Abstract][Full Text] [Related]
19. Integrase interactor 1 in health and disease. Das S Curr Protein Pept Sci; 2015; 16(6):478-90. PubMed ID: 25772157 [TBL] [Abstract][Full Text] [Related]